Implementing Virtual Reality (VR) to Reduce Sedation

Description

The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.

Conditions

Sedative During Endoscopy

Study Overview

Study Details

Study overview

The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.

Pilot Proof of Concept Study for Implementing Virtual Reality (VR) to Reduce Sedation Requirement During Endoscopy

Implementing Virtual Reality (VR) to Reduce Sedation

Condition
Sedative During Endoscopy
Intervention / Treatment

-

Contacts and Locations

Brooklyn

NYU Langone Brooklyn, Brooklyn, New York, United States, 11220

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
  • * Aged 21 to 65
  • * Visual impairments such as blindness which would impair them from watching the entertainment videos.
  • * Patients with history of CAD,
  • * History of seizures,
  • * History of vertigo,
  • * History of allergy to plastic,
  • * ASAII or III,
  • * Patient with active GI bleed, having either melena or hematochezia.

Ages Eligible for Study

21 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

NYU Langone Health,

Maysaa El Zoghbi, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2026-04